Source: Annual Congress 2009 - Malignant pleural mesothelioma guidelines
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
J. Van Meerbeeck (Ghent, Belgium). Pre-therapeutic staging and prognostic factors in malignant pleural mesothelioma patients. Annual Congress 2009 - Malignant pleural mesothelioma guidelines

Member's Comments

No comment yet.

Related content which might interest you: Clinical and morphological prognostic factors in patients with malignant pleura mesothelioma (MPM) Source: Annual Congress 2010 - Current issues in malignant pleural diseases Year: 2010 Prognostic value of treatment outcomes patients with malignant pleural mesothelioma Source: Annual Congress 2010 - Current issues in malignant pleural diseases Year: 2010 Therapeutic outcome and prognostic factors in patients with pleural mesothelioma Source: Eur Respir J 2005; 26: Suppl. 49, 73s Year: 2005 Is comorbidity a good prognostic factor for malignant pleural mesothelioma? Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology Year: 2008 Prognostic factors in diffuse malignant pleural mesothelioma Source: Eur Respir J 2007; 30: Suppl. 51, 755s Year: 2007 Prognostic factors in diffuse malignant pleural mesothelioma Source: Eur Respir J 2003; 22: Suppl. 45, 62s Year: 2003 Prognostic characteristics of malignant pleural mesothelioma Source: International Congress 2017 – Mesothelioma and malignant pleural disease Year: 2017 Diagnosis and staging of malignant pleural mesothelioma Source: ERS Online Course 2020: Calendar sheets in malignant pleural diseases Year: 2020 Prognostic significance of pleural tumour burden in patients with malignant pleural effusions Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement? Year: 2010 Relationship between survival after talc pleurodesis and classic prognostic factors in pleural metastatic breast carcinoma Source: Annual Congress 2008 - Diagnostic and therapeutic approaches in pleural diseases Year: 2008 Clinical and biological prognostic factors in malignant pleural effusion (MPE) secondary to breast cancer Source: Annual Congress 2005 - What's new in the pleura Year: 2005 Prognostic significance of pretreatment clinical and laboratory characteristics in patients with diffuse malignant pleural mesothelioma Source: Eur Respir J 2006; 28: Suppl. 50, 784s Year: 2006 The radiologic evidance in distinguishing the pleural mesothelioma from the pleural metastatic adenocarcinoma Source: Eur Respir J 2006; 28: Suppl. 50, 93s Year: 2006 The analysis of clinicopathological characteristics and prognosis of malignant pleural mesothelioma Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases Year: 2013 Prognostic factors in patients with malignant pleural effusion undergoing thoracoscopy Source: Annual Congress 2011 - From outside to inside: access to the pleura Year: 2011 Prognostic impact of histology and treatment modalities in malignant mesothelioma Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies Year: 2013 Diagnostic value and prognostic significance of pleural C-reactive protein in lung cancer with malignant pleural effusions Source: Annual Congress 2012 - Instructive clinical aspects of thoracic oncology Year: 2012 Malignant pleural mesothelioma: survival-predictive CT elements in 28 patients Source: Eur Respir J 2002; 20: Suppl. 38, 271s Year: 2002 Pathological diagnosis of malignant pleural mesothelioma Source: ERS Online Course 2020: Calendar sheets in malignant pleural diseases Year: 2020 Prognostic significance of serum and pleural mesothelin in malignant pleural mesothelioma (MPM) Source: International Congress 2017 – Mesothelioma and malignant pleural disease Year: 2017